JPS5297926A - Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof - Google Patents

Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof

Info

Publication number
JPS5297926A
JPS5297926A JP1346877A JP1346877A JPS5297926A JP S5297926 A JPS5297926 A JP S5297926A JP 1346877 A JP1346877 A JP 1346877A JP 1346877 A JP1346877 A JP 1346877A JP S5297926 A JPS5297926 A JP S5297926A
Authority
JP
Japan
Prior art keywords
utilization
composition
active compound
pharmaceutically active
preparing pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1346877A
Other languages
English (en)
Japanese (ja)
Inventor
Korinzu Ian
Debitsudo Uitsukusu Fuiritsupu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4929/76A external-priority patent/GB1551260A/en
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of JPS5297926A publication Critical patent/JPS5297926A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1346877A 1976-02-09 1977-02-09 Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof Pending JPS5297926A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4929/76A GB1551260A (en) 1976-02-09 1976-02-09 Phenylethanolamine derivatives
GB3518276 1976-08-24

Publications (1)

Publication Number Publication Date
JPS5297926A true JPS5297926A (en) 1977-08-17

Family

ID=26239472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1346877A Pending JPS5297926A (en) 1976-02-09 1977-02-09 Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof

Country Status (10)

Country Link
US (1) US4154761A (enExample)
JP (1) JPS5297926A (enExample)
AU (1) AU509065B2 (enExample)
CH (1) CH630603A5 (enExample)
DE (1) DE2704895A1 (enExample)
DK (1) DK148444C (enExample)
ES (2) ES455741A1 (enExample)
FR (1) FR2362114A1 (enExample)
NL (1) NL7701304A (enExample)
SE (1) SE440348B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
ATE798T1 (de) * 1978-06-15 1982-04-15 Imperial Chemical Industries Plc Entzuendungshemmende 1-phe nyl-2-aminoaethanol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen zur oertlichen anwendung.
US4304790A (en) * 1979-06-12 1981-12-08 Schering Corporation 2-(Alkylthio, alkylsulfinyl or alkylsulfonyl)-4-[2-anilinoalkylamino)-1-hydroxyethyl]phenols and derivatives thereof
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
PT80304B (en) * 1984-04-17 1987-03-16 Glaxo Group Ltd Process for preparing phenethanolamine compounds
DE3428526A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminoalkohole, verfahren zu deren herstellung sowie diese verbindung enthaltende arzneimittel
US4952729A (en) * 1986-09-05 1990-08-28 Schering-Plough Corp. Intermediates in the preparation of alpha1(((1,1-dimethylethyl) amino) methyl)-4-hydroxy-1,3-benzenedimethanol
US5011993A (en) * 1986-09-05 1991-04-30 Schering Corporation Method for the preparation of α1 [[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol
AU2737295A (en) * 1994-06-09 1996-01-04 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9525121D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT334335B (de) * 1973-03-01 1976-01-10 Basf Ag Verfahren zur herstellung von 1-phenyl-2-aminoathanolen-(1)
AT219581B (de) * 1959-06-26 1962-02-12 Donau Pharmazie Gmbh Verfahren zur Herstellung von neuen Anilinen
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
AT310146B (de) * 1971-04-26 1973-09-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen N,N'-Bis-(β-hydroxyaryläthyl)-diaminoalkanen und deren Säureadditionssalzen
US3879442A (en) * 1972-07-27 1975-04-22 Warner Lambert Co 5-hydroxy-{60 (substituted aminomethyl)-mu-xylene-{60 ,{60 -diols

Also Published As

Publication number Publication date
NL7701304A (nl) 1977-08-11
SE7701379L (sv) 1977-08-10
ES467069A1 (es) 1979-10-16
DK52977A (da) 1977-08-10
AU2213377A (en) 1978-08-17
DK148444B (da) 1985-07-08
SE440348B (sv) 1985-07-29
ES455741A1 (es) 1978-04-16
DE2704895A1 (de) 1977-08-11
FR2362114A1 (fr) 1978-03-17
US4154761A (en) 1979-05-15
AU509065B2 (en) 1980-04-17
DK148444C (da) 1985-12-09
CH630603A5 (de) 1982-06-30
FR2362114B1 (enExample) 1979-03-09

Similar Documents

Publication Publication Date Title
JPS5318546A (en) Novel organic compound process for preparing same and pharmaceutical composition containing same
ZA797054B (en) Pharmaceutically active compounds
JPS5265596A (en) Biologically active compounds and process for producing same
HU175439B (hu) Insekticidnye kompozicii soderzhahhie proizvodnye n-skobka-3-triflorometil-4-galogeno-fenil-skobka zakryta-n-zapjataja vverkh-benzoil-mocheviny i sposob poluchenija aktivnogo agenta
GR61307B (en) Preparation process of pharmacologically active compounds
YU311676A (en) Process for obtaining pharmacologically active compounds
GR60810B (en) Preparation process of pharmaceutically active compounds
PH17548A (en) Pharmacologically active substituted-3-amino-sydnone-imines and process for their preparation
HU172649B (hu) Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
JPS5297926A (en) Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof
JPS5242840A (en) Novel pharmaceutically active compound
GR62562B (en) Preparation process of pharmacologically active compounds
HU173881B (hu) Sposob poluchenija n-skobka-1h-benzimidazol-2-il-skobka zakryta-karbamatov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU175304B (hu) Sposob poluchenija proizvodnykh ksantena s benzolom i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
ZA761324B (en) Pharmaceutically active compounds
JPS5288300A (en) Novel compound and process for preparing same
JPS5265239A (en) Polyene compound and process for preparation thereof
HU174978B (hu) Sposob poluchenija farmacevticheski aktivnykh proizvodnykh izotiokarbamida
JPS52154785A (en) Process for producing nutritive composition
HU178306B (en) Process for preparing pharmaceutically active /omega-amino-alkoxy/-dibenzyl derivatives and acid addition salts thereof
JPS5346928A (en) Novel heart active compound and process for preparation thereof
YU185076A (en) Process for obtaining pharmaceutically active n-(5-tetrazolyl)-pyrimido-(1,2-a)-quinoline-2-caboxamide
JPS5278894A (en) Cephalospoline compound and process for preparing same
JPS52131598A (en) Prganic compound and process for preparing same
JPS52128391A (en) Bisspenicillanoyloxyyalkane compound and process for preparing same